Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AI-CONECT: A Conversational AI for Early Dementia Prevention in Socially-Isolated Older Adults Based on the Efficacy-Proven I-CONECT Study

NCT07701668 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT07701668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07701668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AI-CONECT: A Conversational AI for Early Dementia Prevention in Socially-Isolated Older Adults Based on the Efficacy-Proven I-CONECT Study
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
September 30, 2028
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment (mci), social isolation